Last reviewed · How we verify
NCT05941689
Efficacy of Artificial Intelligence-assisted Colonic Polyp Detection System
NA trial testing AI-assisted colonoscopy in Adenoma Colon in 1,906 participants. Completed in 30 September 2023.
20 September 2023
Quick facts
| Lead sponsor | Xiangya Hospital of Central South University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 1,906 |
| Start date | 25 July 2023 |
| Primary completion | 20 September 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 2 locations across China |
Drugs / interventions tested
- AI-assisted colonoscopy
Conditions studied
- Adenoma Colon — all drugs for Adenoma Colon →
Sponsor
Xiangya Hospital of Central South University
Who can join
Adults 18 to 85, any sex, with Adenoma Colon. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled multicenter clinical trial of computer-aided detection (CADe) system for the adjuvant diagnosis of intestinal polyps/adenomas ever conducted in a Chinese population. In addition, this study will evaluate the effect of CADe system on adenoma detection of endoscopists under fatigue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05941689
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AI-assisted colonoscopy
Trials testing the same drug.
- NCT05740137 — Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy · NA · completed
- NCT05754229 — Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy · NA · unknown
- NCT04335318 — Real Life AI in Polyp Detection · NA · completed
Other recruiting trials for Adenoma Colon
Currently open trials in the same condition.
- NCT07153458 — Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer · recruiting
- NCT07033156 — An Exploratory Study on Gene Methylation Detection of Colorectal Cancer · recruiting
- NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
- NCT06073561 — Underwater Endoscopic Mucosal Resection · NA · recruiting
- NCT04756453 — The Effect of Clip-traction on ESD Resection Time. · NA · recruiting
Other Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07482670 — Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases · not yet recruiting
- NCT07412223 — Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery · Phase 4 · not yet recruiting
- NCT07369960 — Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Glo · NA · recruiting
- NCT07369999 — Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07309913 — China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05941689 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xiangya Hospital of Central South University
- Last refreshed: 10 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05941689.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing